Pulmonary toxicity of FeO, ZnFeO, NiFeO and NiZnFeO nanomaterials: Inflammation and DNA strand breaks.

07:00 EST 21st November 2019 | BioPortfolio

Summary of "Pulmonary toxicity of FeO, ZnFeO, NiFeO and NiZnFeO nanomaterials: Inflammation and DNA strand breaks."

Exposure to metal oxide nanomaterials potentially occurs at the workplace. We investigated the toxicity of two Fe-oxides: FeO nanoparticles and nanorods; and three MFeO spinels: NiZnFeO, ZnFeO, and NiFeO nanoparticles. Mice were dosed 14, 43 or 128 μg by intratracheal instillation. Recovery periods were 1, 3, or 28 days. Inflammation - neutrophil influx into bronchoalveolar lavage (BAL) fluid - occurred for FeO rods (1 day), ZnFeO (1, 3 days), NiFeO (1, 3, 28 days), FeO (28 days) and NiZnFeO (28 days). Conversion of mass-dose into specific surface-area-dose showed that inflammation correlated with deposited surface area and consequently, all these nanomaterials belong to the so-called low-solubility, low-toxicity class. Increased levels of DNA strand breaks were observed for both FeO particles and rods, in BAL cells three days post-exposure. To our knowledge, this is, besides magnetite (FeO), the first study of the pulmonary toxicity of MFeO spinel nanomaterials.


Journal Details

This article was published in the following journal.

Name: Environmental toxicology and pharmacology
ISSN: 1872-7077
Pages: 103303


DeepDyve research library

PubMed Articles [10745 Associated PubMed Articles listed on BioPortfolio]

Peroxidase mimetic activity of porphyrin modified ZnFeO/reduced graphene oxide and its application for colorimetric detection of HO and glutathione.

Artificial nanoenzymes which can overcome some drawbacks of natural enzymes is a challenging topic in the biosensor field. Herein, we demonstrated 5, 10, 15, 20-tetrakis (4-carboxylpheyl)-porphyrin mo...

Effects of physicochemical properties of TiO nanomaterials for pulmonary inflammation, acute phase response and alveolar proteinosis in intratracheally exposed mice.

Nanomaterial (NM) characteristics may affect the pulmonary toxicity and inflammatory response, including specific surface area, size, shape, crystal phase or other surface characteristics. Grouping of...

Protein and lipid homeostasis altered in rat macrophages after exposure to metallic oxide nanoparticles.

Metal oxide nanoparticles (NPs), such as ZnO, ZnFeO, and FeO, are widely used in industry. However, little is known about the cellular pathways involved in their potential toxicity. Here, we particula...

The role of atopy in the pathogenesis of bleomycin pulmonary toxicity.

Bleomycin pulmonary toxicity (BPT) is a potentially life-threatening consequence of bleomycin usage in patients. An overproduction of epithelium-derived cytokines, habitually linked to allergic inflam...

Accelerating the charge separation of ZnFeO nanorods by Cu-Sn ions gradient doping for efficient photoelectrochemical water splitting.

Spinel zinc ferrite (ZnFeO) with an appropriate band gap (2.1 eV) is a promising photoanode in the photoelectrocatalysis field, however, the photoelectrochemical (PEC) performance of ZnFeO is confin...

Clinical Trials [8793 Associated Clinical Trials listed on BioPortfolio]

An Evaluation of Zinc Status Biomarkers

The purpose of this study is to determine the effect of a moderate decrease in dietary zinc on DNA strand breaks and other cellular zinc biomarkers.

A Trial of Niraparib in BAP1 and Other DNA Double-Strand Break Repair Deficient Neoplasms (UF-STO-ETI-001)

This open-label, non-randomized study will investigate the use of niraparib in patients with tumors known to have mutations in BAP1 and other select DNA double-strand break repair pathway ...

Long-term Impact of Pulmonary Rehabilitation

This study has been designed to capture a large group of patients who undergo pulmonary rehabilitation and map their progression over a 5 year time-frame. The outcome measures have been c...

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

This is a prospective, single-center, two-phase study to assess the efficacy of single pulsed-dose flutamide in creating double strand breaks (DSBs) in prostate cancer within patients rece...

Ipilimumab-induced Lung Toxicity: Observational Study

Serial spirometries and measurements of CO-diffusion capacity (DLCO) in patients with MM before and during treatment with ipilimumab are performed. A reduction from baseline of forced vita...

Medical and Biotech [MESH] Definitions

Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.

Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)

Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

DNA that is complementary to the sense strand. (The sense strand has the same sequence as the mRNA transcript. The antisense strand is the template for mRNA synthesis.) Synthetic antisense DNAs are used to hybridize to complementary sequences in target RNAs or DNAs to effect the functioning of specific genes for investigative or therapeutic purposes.

A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Quick Search

DeepDyve research library

Relevant Topics

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Searches Linking to this Article